Food & Recipes
Internet & Social Media
Lupin Q4 income
15 May 2018
Lupin Q4 net loss at Rs 783 crore
The company had reported a net profit of Rs 380.21 crore for the same period of 2016-17.
BSE's benchmark index
17 Nov 2017
IndusInd Bank, Yes Bank to join BSE Sensex; Cipla, Lupin exit
The changes are announced by Asia Index, a joint venture between S&P Dow Jones Indices LLC and BSE. The move is a part of Asia Index's semi-annual reconstitution results.
26 May 2017
Investor wealth surges over Rs 50 lakh crore in 3 years
Investor wealth has surged by over Rs 50 lakh crore since the Modi government was voted to power three years ago, with the Sensex surging to its lifetime high of 31,074.07 on Friday.
03 May 2017
Lupin extends losses, loses m-cap by Rs 3,315 crore in 2 days
Registering losses for the second day, Lupin on Wednesday fell by 3 percent on US health regulator's observations for its Goa plant.
02 Mar 2017
Pharma giant Lupin embarks on generic drug treatment to treat depression in US
We have launched generic Pristiq (Desvenlafaxine Succinate) extended-release tablets, 50 mg and 100 mg having received an approval from the United States Food and Drug Administration (FDA) earlier.
28 Feb 2017
Pharma major Lupin gets USFDA nod to market colonoscopy drugs, pain relief
The approved product is indicated for relief of moderate to moderately severe pain. Percocet tablets had US sales of USD 838.7 million.
26 Dec 2016
Lupin receives USFDA nod for hypertension treatment drug in US
Drug major Lupin has received tentative approval from the US health regulator to sell Olmesartan medoximil tablets, used for treating high blood pressure, in the American market.
27 Sep 2016
Brokerage view on the stocks of 'Lupin, Idea, JP Morgan etc
06 Sep 2016
Lupin gets USFDA tentative nod for anti-bacterial tablets
Drug firm Lupin has received tentative approval from the US health regulator to market its generic anti-bacterial moxifloxacin hydrochloride tablets in the American market.
TCS and Infosys
26 Jul 2016
TCS, Infosys in Forbes 'Super 50' list; Tata Motors, HUL dropped
Software majors TCS and Infosys, pharma giants Sun Pharma and Lupin and private sector lenders HDFC Bank and Axis Bank feature in Forbes India's Super 50 List this year, while biggies like Tata Motors and HUL have been dropped.
07 Jul 2016
USFDA clears Lupin's Goa facility; stocks up 6.25%
Pharma firm Lupin has received Establishment Inspection Report (EIR) from the US health regulator for its Goa facility regarding a inspection done by the USFDA in July last year.
Drug major Lupin
13 Jun 2016
Committed to close corrective action at Goa by Dec: Lupin
New Delhi: Drug major Lupin has committed to close the corrective action at its Goa facility, which had received nine observations from US health regulator, by December.
11 Apr 2016
Lupin to market Novartis' inhaler under Loftair brand name
Drug major Lupin and Novartis Healthcare have inked a co-marketing agreement under which Lupin will market Novartis' inhaler, used to treat chronic obstructive pulmonary disease, under the brand name Loftair in India
05 Apr 2016
Lupin launches generic insomnia drug in US
Drug major Lupin has launched a generic insomnia drug, Zolpidem Sublingual tablets, in the US market with 180-days of marketing exclusivity.
31 Mar 2016
Lupin launches generic Aricept tablets in US market
Drug major Lupin has launched Donepezil Hydrochloride tablets, used in treating Alzheimer's disease, in the US market after having received the US health regulator USFDA's nod for the product earlier
29 Mar 2016
Lupin shares hit 52-week low; tank over 14%
Shares of pharma firm Lupin today tumbled over 14 per cent to hit their one-year low level amid reports of regulatory concerns at one of its unit.
19 Mar 2016
10 best companies to work for in India
10 Indian companies made it to the list under the '25 Best Large Places to Work'
15 Mar 2016
Lupin receives nine observations from USFDA for Goa plant
Drug major Lupin on Tuesday says that it has received nine observations relating to inadequacy and adherence to operating norms for its manufacturing plant in Goa from the US Food and Drug Administration (USFDA)
05 Feb 2016
Expert view on Lupin stocks
05 Feb 2016
Lupin Q3 net profit dips 12% to Rs 530 crore
The company had posted a net profit of Rs 601.45 crore in the same period of the previous fiscal.
DNA: 'Project Report' of construction of Ram Mandir in Ayodhya
DNA: A volcano of anger erupts in Israel
DNA: Was there a delay from Congress's 'army of lawyers'?
DNA : Rahul follows footsteps of Indira and Sonia
DNA: Will India be TB free by 2025?
DNA: New Zealand launches 'Love Better Campaign' to help people suffering from breakup
DNA: 'Supreme Debate' on death penalty, is death penalty by hanging cruel?
DNA: Ram Manohar Lohia, 'Unparalleled warrior of politics of resistance against injustice'
DNA : Analysis of encroachment in the fort of Pandavas
DNA: What is the significance of Putin's presence in Mariupol?